The global market for Small Nucleic Acid Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Small Nucleic Acid Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Small Nucleic Acid Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Small Nucleic Acid Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Small Nucleic Acid Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Small Nucleic Acid Drug players cover Ionis Pharmaceuticals, Sarepta Therapeutics, Alnylam Pharmaceuticals, Biogen and Nippon Shinyaku. etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Small Nucleic Acid Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Small Nucleic Acid Drug market, with both quantitative and qualitative data, to help readers understand how the Small Nucleic Acid Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Small Nucleic Acid Drug market and forecasts the market size by Type (siRNA Drug and ASO Drug,), by Application (Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Cancer and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
siRNA Drug
ASO Drug
Segmentation by application
Duchenne Muscular Dystrophy
Spinal Muscular Atrophy
Cancer
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Ionis Pharmaceuticals
Sarepta Therapeutics
Alnylam Pharmaceuticals
Biogen
Nippon Shinyaku
Chapter Introduction
Chapter 1: Scope of Small Nucleic Acid Drug, Research Methodology, etc.
Chapter 2: Executive Summary, global Small Nucleic Acid Drug market size (sales and revenue) and CAGR, Small Nucleic Acid Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Small Nucleic Acid Drug sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Small Nucleic Acid Drug sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Small Nucleic Acid Drug market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Ionis Pharmaceuticals, Sarepta Therapeutics, Alnylam Pharmaceuticals, Biogen and Nippon Shinyaku, etc.
Chapter 14: Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Small Nucleic Acid Drug. Industry analysis & Market Report on Small Nucleic Acid Drug is a syndicated market report, published as Global Small Nucleic Acid Drug Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Small Nucleic Acid Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.